The incidence and mortality of cutaneous melanoma in Southern Germany: Trends by anatomic site and pathologic characteristics, 1976 to 2003

Cancer

Volumn 107, Issue 6, 2006, Pages 1331-1339

  Lasithiotakis, Konstantinos G ^a   Leiter, Ulrike ^a   Gorkievicz, Roman ^a   Eigentler, Thomas ^a   Breuninger, Helmut ^a   Metzler, Gisela ^a   Strobel, Waltraud ^a   Garbe, Claus ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Central Baden Wurttemberg; Clinical characteristics; Cutaneous melanoma; Incidence; mortality; Southern Germany

Indexed keywords

ADULT; AGED; ARTICLE; AWARENESS; CANCER INCIDENCE; CANCER MORTALITY; CAUCASIAN; EUROPE; FEMALE; GERMANY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MORTALITY; PATHOLOGICAL ANATOMY; POPULATION RISK; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; EXTREMITIES; FEMALE; GERMANY; HEAD; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; MORTALITY; NECK; REGISTRIES; SKIN; SKIN NEOPLASMS;

EID: 33749021082     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22126     Document Type: Article

References (31)

1. de Vries E, Bray FI, Coebergh JW, Parkin DM, Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer. 2003;107:119-126.
2. Edwards BK, Brown ML, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005;97:1407-1427.
3. Levi F, Te VC, Randimbison L, La Vecchia C. Trends in incidence of various morphologies of malignant melanoma in Vaud and Neuchatel, Switzerland. Melanoma Res. 2005;15:73-75.
4. Marrett LD, Nguyen HL, Armstrong BK. Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996. Int J Cancer. 2001;92:457-462.
5. Bosetti C, La Vecchia C, Naldi L, Lucchini F, Negri E, Levi F. Mortality from cutaneous malignant melanoma in Europe. Has the epidemic levelled off? Melanoma Res. 2004;14:301-309.
6. MacKie RM, Bray CA, Hole DJ, et al. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet. 2002;360:587-591.
7. Severi G, Giles GG, Robertson C, Boyle P, Autier P. Mortality from cutaneous melanoma: evidence for contrasting trends between populations. Br J Cancer. 2000;82:1887-1891.
8. Buettner PG, Leiter U, Eigentler TK, Garbe C. Development of prognostic factors and survival in cutaneous melanoma over 25 years: an analysis of the Central Malignant Melanoma Registry of the German Dermatological Society. Cancer. 2005;103:616-624.
9. Garbe C, McLeod GR, Buettner PG. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer. 2000;89:1269-1278.
10. Kim H, Fay M, Feuer E, Midthune D. Permutation tests for jointpoint regression with application to cancer rates. Stat Med. 2000;19:335-351.
11. World Health Organization. GLOBOCAN: Cancer Incidence, Mortality and Prevalence Worldwide. IARC cancer base no. 5, version 1.0. Lyon: IARC; 2001.
12. Stang A, Stang K, Stegmaier C, Hakulinen T, Jockel KH. Skin melanoma in Saarland: incidence, survival and mortality 1970-1996. Eur J Cancer Prev. 2001;10:407-415.
13. Balzi D, Carli P, Giannotti B, Paci E, Buiatti E. Cutaneous melanoma in the Florentine area, Italy: incidence, survival and mortality between 1985 and 1994. Eur J Cancer Prev. 2003;12:43-48.
14. Garbe C, Paul A, Kohler-Spath H, et al. Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy. J Clin Oncol. 2003;21:520-529.
15. Blum A, Schlagenhauff B, Stroebel W, Breuninger H, Rassner G, Garbe C. Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma: results of a prospective study of 1288 patients. Cancer. 2000;88:2534-2539.
16. Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst. 2001;93:678-683.
17. Coory M, Baade P, Aitken J, Smithers M, McLeod GR, Ring I. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002. Cancer Causes Control. 2006;17:21-27.
18. Swetter SM, Boldrick JC, Jung SY, Egbert BM, Harvell JD. Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000. J Invest Dermatol. 2005;125:685-691.
19. Demierre MF, Chung C, Miller DR, Geller AC. Early detection of thick melanomas in the United States: beware of the nodular subtype. Arch Dermatol. 2005;151:745-750.
20. Chamberlain AJ, Fritschi L, Giles GG, Dowling JP, Kelly JW. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. Arch Dermatol. 2002;138:609-614.
21. Chamberlain AJ, Fritschi L, Kelly JW. Nodular melanoma: patients' perceptions of presenting features and implications for earlier detection. J Am Acad Dermatol. 2003;48:694-701.
22. Abbasi NR, Shaw HM, Rigel DS, et al. Early diagnosis of cutaneous melanoma. Revisiting the ABCD criteria. JAMA. 2004;292:2771-2776.
23. Weinstock MA. Early detection of melanoma. JAMA. 2000;284:886-889.
24. Lehnert M, Eberle A, Hentschel S, et al. [Malignant melanoma of the skin as evidenced by epidemiological cancer registries in Germany-incidence, clinical parameters, variations in recording]. Gesundheitswesen. 2005;67:729-735.
25. Lange JR, Balch CM. Screening for cutaneous melanoma. Surg Oncol Clin N Am. 2005;14:799-811.
26. de Vries E, van de Poll-Franse LV, Louwman WJ, de Gruijl FR, Coebergh JW. Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol. 2005;152:481-488.
27. Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med. 1999;340:1341-1348.
28. Bulliard JL. Site-specific risk of cutaneous malignant melanoma and pattern of sun exposure in New Zealand. Int J Cancer. 2000;85:627-632.
29. Gallagher RP, Spinelli JJ, Lee TK. Tanning beds, sunlamps, and risk of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev. 2005;14:562-566.
30. Whiteman DC, Watt P, Purdie DM, Hughes MC, Hayward NK, Green AC. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst. 2003;95:806-812.
31. Lasithiotakis K, Kruger-Krasagakis S, Ioannidou D, et al. Epidemiological differences for cutaneous melanoma in a relatively dark-skinned Caucasian population with chronic sun exposure. Eur J Cancer. 2004;40:2502-2507.